SMS Pharmaceuticals Ltd - 532815 - Please Find Attached The Press Release On The Financial Results For The Quarter Ended June 30, 2021.
Please find attached the press release on the Financial Results for the quarter ended June 30, 2021. Kindly take the same on record. SMS PHARMACEUTICALS LTD. - 532815 - Publishing Of Financial Results In Newspaper Ref: Regulation 47(1)(B) Of SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015
Further to our intimation dated 7th August, 2021, please find the enclosed herewith copies of the newspaper advertisements published on 8th August, 2021, regarding financial results for the first ended as on 30th June, 2021. Please that this information is published within 48 hours of closure of the Board Meeting as specified in Regulation 47(3) of SEBI (Listing obligations & Disclosure Requirements) regulations, 2015. SMS Pharmaceuticals Ltd - 532815 - Outcome Of Board Meeting Held On 7Th August, 2021 - Revised
With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held on today, inter-alia considered and approved the following: 1. Approved the Standalone and Consolidated Un-audited Financial Results for the Quarter ended 30th June, 2021 along with the Limited Review Report 2. Reclassification of promoter group shareholding from promoter category to public category. 3. Directors Report by the Board for the FY 2020-21 4. Convening the 33rd Annual General Meeting on 30th, September, 2021 5. Dividend Distribution Policy SMS PHARMACEUTICALS LTD. - 532815 - Intimation Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to our earlier communication dated 31st July, 2021 we would like to inform you that the Board of Directors at its meeting held today have approved for reclassification of the following shareholders from Promoter to Public Category: SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th August, 2021
With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held on today, inter-alia considered and approved the following: 1. Approved the Standalone and Consolidated Un-audited Financial Results for the Quarter ended 30th June, 2021 along with the Limited Review Report 2. Reclassification of promoter group shareholding from promoter category to public category. 3. Directors Report by the Board for the FY 2020-21 4. Convening the 33rd Annual General Meeting on 30th, September, 2021 5. Dividend Distribution Policy SMS PHARMACEUTICALS LTD. - 532815 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Advertisement In News Paper.
With reference to subject cited above we are herewith enclosing the copies of advertisement issued in newspapers on 1st August, 2021 in 'Financial Express' in English language and in 'Andhra Prabha' in Telugu Language, with respect to intimation of Board Meeting for considering Un-audited financial results for the quarter ended 30th June, 2021. SMS Pharmaceuticals Ltd - 532815 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On 7Th August, 2021
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2021 ,inter alia, to consider and approve 1. To consider and approve the Un-audited Financial results of the Company for the First Quarter ended on 30th June, 2021. 2. To consider the board report for the financial year 2020-21 3. To fix the date of Annual General Meeting for the financial year 2020-21 4. To consider the request received for reclassification of shareholding from Promoter Category to Public Category pursuant to Regulation 31(A) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. SMS Pharmaceuticals Ltd - 532815 - Intimation Under Regulation 31(A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
With reference to the caption subject, we would like to inform the Exchange that the Company has received request on 31st July, 2021 from the following persons to re-classify their shareholding in the company from Promoter Category to Public Category pursuant to Regulation 31(A) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. SMS Pharmaceuticals Ltd - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June, 2021 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate dated 7th July, 2021, received from Aarthi Consultants Private Limited, Hyderabad, the Registrar and Share Transfer Agent of the Company for the quarter ended 30th June, 2021. SMS PHARMACEUTICALS LTD. - 532815 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ramesh Babu PotluriDesignation :- Managing Director / Whole Time Director